• OPEN AN ACCOUNT
Indian Indices
Nifty
18,487.75 -46.65
(-0.25%)
Sensex
62,547.11 118.57
( 0.19%)
Bank Nifty
43,790.20 -337.95
( -0.77%)
Nifty IT
29,446.25 126.50
( 0.43%)
Global Indices
Nasdaq
13,100.98 165.69
(1.28%)
Dow Jones
33,061.57 153.30
(0.47%)
Hang Seng
18,949.94 733.03
(4.02%)
Nikkei 225
31,524.22 376.21
(1.21%)
Forex
USD-INR
82.41 -0.27
(-0.32%)
EUR-INR
88.32 -0.29
(-0.33%)
GBP-INR
102.83 0.40
(0.39%)
JPY-INR
0.59 0.00
(0.25%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
305.2452925
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
29.93
77830.13
EPS(TTM)
Face Value()
Div & Yield %
32.22
2
0.88
 

cipla ltd
Cipla Ltd - Cipla Limited - Diversification/Disinvestment
Mar 15,2023
Cipla Limited and its wholly owned subsidiaries, Cipla (EU) Limited, UK and Meditab Holdings Limited, Mauritius, have entered into a Share Purchase Agreement with Africa Capitalworks SSA 3 on 14th March 2023 for sale of 51.18% stake held in Cipla Quality Chemical Industries Limited (CQCIL), Uganda. Subsequent to the sale, CQCIL will cease to be a subsidiary of the Company.